Kappos L - Search Results

1

Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple Sclerosis.

Sanabria-Diaz G, Cagol A, Lu PJ, Barakovic M, Ocampo-Pineda M, Chen X, Weigel M, Ruberte E, Siebenborn NOS, Galbusera R, Schädelin S, Benkert P, Kuhle J, Kappos L, Melie-Garcia L, Granziera C. Sanabria-Diaz G, et al. Among authors: kappos l. Ann Neurol. 2024 Oct 10. doi: 10.1002/ana.27102. Online ahead of print. Ann Neurol. 2024. PMID: 39390658

2

MRI study of Baló's concentric sclerosis before and after immunosuppressive therapy.

Spiegel M, Krüger H, Hofmann E, Kappos L. Spiegel M, et al. Among authors: kappos l. J Neurol. 1989 Dec;236(8):487-8. doi: 10.1007/BF00328514. J Neurol. 1989. PMID: 2614497

3

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study.

Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH. Filippi M, et al. Among authors: kappos l. Neurology. 1995 Feb;45(2):255-60. doi: 10.1212/wnl.45.2.255. Neurology. 1995. PMID: 7854522 Clinical Trial.

4

Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

Kappos L, Kuhle J, Gass A, Achtnichts L, Radue EW. Kappos L, et al. J Neurol. 2004 Sep;251 Suppl 5:v57-v64. doi: 10.1007/s00415-004-1509-6. J Neurol. 2004. PMID: 15549357 Review.

5

Genomics and proteomics: role in the management of multiple sclerosis.

Kappos L, Achtnichts L, Dahlke F, Kuhle J, Naegelin Y, Sandbrink R, Lindberg RL. Kappos L, et al. J Neurol. 2005 Sep;252 Suppl 3:iii21-iii27. doi: 10.1007/s00415-005-2013-3. J Neurol. 2005. PMID: 16170496 Review.

6

Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis.

Weder C, Baltariu GM, Wyler KA, Gober HJ, Lienert C, Schluep M, Radü EW, De Libero G, Kappos L, Duda PW. Weder C, et al. Among authors: kappos l. Eur J Neurol. 2005 Nov;12(11):869-78. doi: 10.1111/j.1468-1331.2005.01084.x. Eur J Neurol. 2005. PMID: 16241976

7

Lack of association between antimyelin antibodies and progression to multiple sclerosis.

Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung HP, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L, Sandbrink R. Kuhle J, et al. Among authors: kappos l. N Engl J Med. 2007 Jan 25;356(4):371-8. doi: 10.1056/NEJMoa063602. N Engl J Med. 2007. PMID: 17251533 Free article. Clinical Trial.

8

Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.

Kuhle J, Lindberg RL, Regeniter A, Mehling M, Hoffmann F, Reindl M, Berger T, Radue EW, Leppert D, Kappos L. Kuhle J, et al. Among authors: kappos l. J Neurol. 2007 Feb;254(2):160-8. doi: 10.1007/s00415-006-0299-4. J Neurol. 2007. PMID: 17334662

9

Health-related quality of life in multiple sclerosis: effects of natalizumab.

Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; AFFIRM and SENTINEL Investigators. Rudick RA, et al. Among authors: kappos l. Ann Neurol. 2007 Oct;62(4):335-46. doi: 10.1002/ana.21163. Ann Neurol. 2007. PMID: 17696126 Clinical Trial.

10

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.

Lindberg RL, Achtnichts L, Hoffmann F, Kuhle J, Kappos L. Lindberg RL, et al. Among authors: kappos l. J Neuroimmunol. 2008 Feb;194(1-2):153-64. doi: 10.1016/j.jneuroim.2007.11.007. Epub 2008 Feb 21. J Neuroimmunol. 2008. PMID: 18178259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

810 results

Search Page

Filters